MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.juro.2013.07.012

Медицинская библиотека · The Journal of urology · 2013

Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.

Krabbe Laura-Maria, Bagrodia Aditya, Lotan Yair, Gayed Bishoy A, Darwish Oussama M, Youssef Ramy F, John George, Harrow Brian, Jacobs Corbin, Gaitonde Mansi, Sagalowsky Arthur I, Shariat Shahrokh F, Kapur Payal, Margulis Vitaly

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: We determined the association of the proliferation marker Ki-67 with pathological parameters and oncologic outcomes in patients with high grade upper tract urothelial carcinoma.

MATERIALS AND

METHODS

Immunohistochemical staining for Ki-67 was done prospectively in 101 consecutive patients undergoing radical nephroureterectomy/ureterectomy for high grade upper tract urothelial carcinoma. Data were compared based on Ki-67 status (normal vs over expressed). Survival was assessed by the Kaplan-Meier method. Cox regression analysis was done to identify independent predictors of time dependent outcomes.

RESULTS

Median patient age was 70.0 years and median followup was 22.0 months (range 1 to 77). Overall, 30.2% of the population experienced recurrence and 24.8% died of upper tract urothelial carcinoma. Organ confined disease (T2 or less and lymph node negative), lymphovascular invasion and sessile architecture were present in 56.3%, 33.3% and 20.8% of patients, respectively. Ki-67 was over expressed in 73.3% of patients and associated with adverse pathological features. Patients with over expressed Ki-67 had significantly worse recurrence-free survival (43.2 vs 69.0 months, p = 0.006) and cancer specific survival (48.9 vs 68.9 months, p = 0.031) than patients with normal Ki-67. Patients with nonmetastatic disease similarly had worse recurrence-free survival (40.7 vs 71.8 months, p = 0.003) and cancer specific survival (41 months vs not attained, p = 0.008) for over expressed vs normal Ki-67. After adjusting for the effects of organ vs nonorgan confined disease Ki-67 over expression was an independent predictor of recurrence-free survival in the total cohort (HR 4.3, p = 0.05) and in patients with nonmetastatic disease (HR 8.5, p = 0.038).

CONCLUSIONS

Ki-67 over expression was associated with adverse pathological features in cases of upper tract urothelial carcinoma. It was also an independent predictor of recurrence-free survival in patients with high grade upper tract urothelial carcinoma.

Для цитирования: Krabbe Laura-Maria, Bagrodia Aditya, Lotan Yair, Gayed Bishoy A, Darwish Oussama M, Youssef Ramy F, John George, Harrow Brian, Jacobs Corbin, Gaitonde Mansi, Sagalowsky Arthur I, Shariat Shahrokh F, Kapur Payal, Margulis Vitaly. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.. The Journal of urology. 2013. DOI: 10.1016/j.juro.2013.07.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.